MedPath

PACLITAXEL INJECTION USP

PACLITAXEL INJECTION USP

Approved
DIN Number

02391465

Drug Class

Human

Market Date

Jul 2, 2014

Company
HC

Accord Healthcare Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02391465
AIG Number0124214001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CD01 PACLITAXEL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PACLITAXELActive
Strength: 6 MG / ML
Monograph: PACLITAXEL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.